Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;32(1):267-273.
doi: 10.1111/jvim.14851. Epub 2017 Dec 15.

Evaluation of the Live Biotherapeutic Product, Asymptomatic Bacteriuria Escherichia coli 2-12, in Healthy Dogs and Dogs with Clinical Recurrent UTI

G Segev  1 , J E Sykes  2 , D J Klumpp  3 , A J Schaeffer  3 , E M Antaki  4 , B A Byrne  5 , R E Yaggie  3 , J L Westropp  2
Affiliations

Evaluation of the Live Biotherapeutic Product, Asymptomatic Bacteriuria Escherichia coli 2-12, in Healthy Dogs and Dogs with Clinical Recurrent UTI

G Segev et al. J Vet Intern Med. 2018 Jan.

Abstract

Background: Antimicrobial resistance is an emerging problem.

Hypothesis/objective: To investigate the safety and efficacy of a live biotherapeutic product, ASB E. coli 2-12 for UTI treatment.

Animals: Six healthy research dogs; nine client-owned dogs with recurrent UTI.

Methods: Prospective noncontrolled clinical trial. For safety data, research dogs were sedated, a urinary catheter was inserted into the bladder; 1010 CFU/mL of ASB E. coli 2-12 was instilled. Urine was cultured on days 1, 3, and 8 post-instillation and dogs were observed for lower urinary tract signs (LUTS). For client-owned dogs, ASB E. coli 2-12 was instilled similarly and urine cultures analyzed on days 1, 7, and 14 days postinstillation.

Results: No LUTS were noted in any of the 6 research dogs after ASB E. coli 2-12 infusion. Pulse field gel electrophoresis (PFGE) studies confirmed the bacterial strains isolated matched that ASB E. coli 2-12 strain. Four of the nine client-owned dogs had complete or nearly complete clinical cures by day 14. Of these four dogs, 3 also had microbiologic cures at day 14; one of these dogs had subclinical bacteriuria (in addition to ASB E. coli 2-12). Three of these four dogs had ASB E. coli 2-12 isolated from their urine at day 14. With the exception of mild, temporary, self-limiting, hyporexia in two dogs on the day of biotherapeutic administration, there were no major adverse effects.

Conclusions and clinical importance: These results suggest ASB E. coli 2-12 is safe and should be investigated in a larger controlled study evaluating clinical UTI in dogs.

Keywords: Antimicrobial resistance; Cystitis; Dog; Urinary tract.

PubMed Disclaimer

Conflict of interest statement

Jane Sykes serves as Associate Editor of the Journal of Veterinary Internal Medicine. She was not involved in the review of this manuscript.

Figures

Figure 1
Figure 1
Pulse field gel electrophoresis profiles from urine E.coli isolated from research dogs. Lane 2 is ASB E coli 2‐12 (lane 2) control from the lyophilized sample. Lanes 3‐9 represent the seven E. coli isolates obtained from the research dogs after bladder instillation. The E. coli isolates were genetically identical. Low range PFGE biomarkers are represented in lanes 1 and 10.
Figure 2
Figure 2
Scatter plot of voiding diary scores of the dogs that had clinical improvements noted. Dash line indicates the median.
See this image and copyright information in PMC

References

    1. Ling GV. Therapeutic strategies involving antimicrobial treatment of the canine urinary tract. J Vet Med Assoc 1984;185:1162–1164. - PubMed
    1. Westropp JL, Sykes JE, Irom S, et al. Evaluation of the efficacy and safety of high dose short duration enrofloxacin treatment regimen for uncomplicated urinary tract infections in dogs. J Vet Intern Med 2012;26:506–512. doi: . Epub 2012 Apr 4. - DOI - PMC - PubMed
    1. Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Am J Med 2002;113(Suppl 1A):5S–13S. - PubMed
    1. Seguin MA, Vaden SL, Altier C, et al. Persistent urinary tract infections and reinfections in 100 dogs (1989‐1999). J Am Vet Intern Med 2003;17:622–631. - PubMed
    1. Norris CR, Williams BJ, Ling GV, et al. Recurrent and persistent urinary tract infections in dogs: 383 cases (1969‐1995). J Am Anim Hos Assoc 2000;36:484–492. - PubMed